We are live on ! Find out more
EAM

Eagle Asset Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 41.58%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+41.58%
3 Year Est. Return
+53.38%
5 Year Est. Return
+214.12%
10 Year Est. Return
+691.23%
AUM
$22.1B
AUM Growth
-$1.14B
Cap. Flow
-$1.14B
Cap. Flow %
-5.15%
Top 10 Hldgs %
11.34%
Holding
628
New
31
Increased
162
Reduced
387
Closed
38

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$108M
2
RCL icon
Royal Caribbean
RCL
+$99M
3
MRNA icon
Moderna
MRNA
+$84M
4
LLY icon
Eli Lilly
LLY
+$83.2M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.34%
3 Industrials 14.38%
4 Consumer Discretionary 11.98%
5 Financials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLMB icon
576
Climb Global Solutions
CLMB
$528M
$244K ﹤0.01%
36,380
AGZ icon
577
iShares Agency Bond ETF
AGZ
$559M
$242K ﹤0.01%
2,044
+117
+6% +$13.9K
ADI icon
578
Analog Devices
ADI
$172B
$204K ﹤0.01%
+1,223
New +$205K
TEVA icon
579
Teva Pharmaceuticals
TEVA
$40.4B
$171K ﹤0.01%
17,640
+1,713
+11% +$16K
SEI
580
Solaris Energy Infrastructure
SEI
$2.66B
$91K ﹤0.01%
10,999
-1,166
-10% -$9.46K
KRMD icon
581
KORU Medical Systems
KRMD
$187M
$87K ﹤0.01%
30,831
+5,069
+20% +$16.8K
BGC icon
582
BGC Group
BGC
$5.64B
$66K ﹤0.01%
12,767
SCTL
583
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$66K ﹤0.01%
32,280
+11,073
+52% +$23.6K
ATRS
584
DELISTED
Antares Pharma, Inc.
ATRS
$62K ﹤0.01%
17,161
+5,845
+52% +$23.6K
ATIP
585
DELISTED
ATI Physical Therapy, Inc.
ATIP
$52K ﹤0.01%
+274
New +$69.8K
SRGA
586
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$38K ﹤0.01%
1,183
+271
+30% +$9.92K
QTNT
587
DELISTED
Quotient Limited Ordinary Shares
QTNT
$26K ﹤0.01%
283
CSLT
588
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$25K ﹤0.01%
16,123
-3,492
-18% -$6.84K
BIOR
589
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$24K ﹤0.01%
64
ADMA icon
590
ADMA Biologics
ADMA
$2.02B
$20K ﹤0.01%
18,552
AI icon
591
C3.ai
AI
$1.38B
-347,857
Closed -$21.8M
ALRM icon
592
Alarm.com
ALRM
$2.75B
-82,697
Closed -$7M
BSX icon
593
Boston Scientific
BSX
$68.4B
-6,286
Closed -$268K
CRCT icon
594
Cricut
CRCT
$1.01B
-1,117,658
Closed -$47.6M
CVGW
595
DELISTED
Calavo Growers
CVGW
-87,704
Closed -$5.56M
DD icon
596
DuPont de Nemours
DD
$18.6B
-10,635
Closed -$1.03M
EAF icon
597
GrafTech
EAF
$184M
-28,661
Closed -$3.33M
EFSC icon
598
Enterprise Financial Services Corp
EFSC
$2.4B
-157,604
Closed -$7.31M
FCX icon
599
Freeport-McMoran
FCX
$86.2B
-71,229
Closed -$2.64M
FIBK icon
600
First Interstate BancSystem
FIBK
$3.67B
-251,885
Closed -$10.5M

Similar funds

Eagle Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Eagle Asset Management held 628 positions worth $22.1B, down 4.9% from $23.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Eagle Asset Management withdrew a net $1.14B in Q3 2021, closing 38 positions and reducing 387 holdings. Its most notable exit was Royal Caribbean, an estimated $99M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Eagle Asset Management opened a new position in Xilinx Inc worth $85.5M.

  • Eagle Asset Management's largest Q3 2021 buy was Xilinx Inc: 566,131 shares worth $85.5M.
  • Eagle Asset Management added most to United Parcel Service in Q3 2021, an estimated $92M increase.
  • Eagle Asset Management's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $108M.
  • Eagle Asset Management fully exited Royal Caribbean in Q3 2021, selling an estimated $99M.
  • Eagle Asset Management's ten largest holdings make up 11% of its $22.1B portfolio in Q3 2021.
  • Eagle Asset Management opened 31 new positions and closed 38 in Q3 2021.
  • Eagle Asset Management's portfolio value fell 4.9% quarter-over-quarter to $22.1B.

Based on Eagle Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.